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Introduction 39
Immunocompromised mice engrafted with human immune systems (i.e. "humanized" mice) are powerful pre-clinical 40 models for studying human immune cell function. However, the translational value of these mice has not been fully 41 realized, particularly in preclinical models of neuroinflammation and central nervous system (CNS) injury. Previously, 42
we documented the feasibility of using humanized mice to study systemic and neuroinflammatory changes caused by 43 traumatic spinal cord injury (SCI) (Carpenter et al., 2015). We did not explore developmental changes in the human 44 immune systems of these mice. Specifically, the relative changes in the composition or function of the various human 45 immune cells that could elicit neuroinflammation and systemic immunity after SCI. These are important variables to 46 understand since there are conflicting data regarding the functional competency of human immune cells in humanized 47 mouse models. Some studies indicate that human immune cells can develop in mice but they are not functional 48 (Danner et blood (UCB) stem cells to engraft bone marrow and secondary lymphoid tissues (e.g., spleen, lymph nodes) of 59 IL2 (rhIL2), human T cells increased expression of hCD69 ( Fig. 2A,B) , a cell activation marker, accompanied by 120 robust proliferation ( Fig. 2C,D; Fig. 2-figure supplement 1C ) and production of human IFNg and IL-10 ( Fig. 2E,F) . 121 122
When stimulated with a hCD40 activating antibody (clone 5C3) and rhIL4, purified human B cells increased hCD69 123 expression ( Fig. 2A,B ) but did not proliferate or produce cytokines ( Fig. 2C-F) . However, stimulation of human T cells 124 with hCD3/28 and rhIL2 induced robust hCD19 + B cell proliferation ( Fig. 2C) , suggesting human T and B cell 125
interactions are necessary for mediating human B cell function. 126 127
Lipopolysaccharide (LPS), a canonical activator of toll-like receptor 4 (TLR4) found mostly on myeloid cells, also 128 increased proliferation and production of human cytokines by human splenocytes (Fig. 2C-F) . Similarly, LPS injected 129 in vivo (3mg/kg, i.p.) elicited production of human TNFα (hTNFα) by 1-hour post-injection ( Fig. 2G) . Human TNFα was 130 not detected in serum from naive hNSG mice or non-humanized NSG mice injected with LPS. We also detected 131
human IgG and IgM antibodies in blood serum of hNSG mice but not non-humanized NSG mice (Fig. 2H,I) . Together, 132 these data prove that human immune cells from hNSG mice are functional; they respond ex vivo and in vivo to 133 physiologically-relevant stimuli, producing a range of immune effector molecules (e.g., cytokines, antibodies that the composition, relative density and functional maturity of human immune cells increases as a function of time 139 post-engraftment in humanized mice. Thus, one would predict that the effects of SCI on immune system activation and 140 the subsequent effects of neuroinflammation and lesion histopathology will change as a function of time post-141 engraftment. To test this hypothesis, a single human UCB donor was used to generate two cohorts of hNSG mice born 142 2 months apart. Both groups received a SCI at the same time -one at 2 months post-engraftment and the other at 4 143 months post-engraftment. Both cohorts survived to 35 days post-injury (dpi). Consistent with data from Fig. 1 , 144 Figure 1. Long-lived engraftment of human immune systems in NSG mice occurs without toxicity. Human immune systems were derived from hCD34 + umbilical cord blood stem cells. A) Engraftment efficiency in mice is affected by time post-engraftment and source of stem cells. UCB = umbilical cord blood, BM = bone marrow. Data average ± SD; *p<0.05 ***p<0.001 compared to 2 months post-engraftment (UCB CD34 + only), oneway ANOVA with Tukey's multiple comparison test. B) Proportion of human CD45 + peripheral blood leukocyte (PBL) subsets. C) Human CD45+ cells in the blood (BLD), bone marrow (BM), and spleen (SPL) of hNSG mice 4-6 months post-engraftment. D,E) Human immune subsets (hCD3, hCD19, and hCD33) in blood (D) and spleen (E) of hNSG mice 4-6 months post-engraftment. F,G) Human CD3 + , CD4 + , and CD8 + T cells identified in thymus (F) and spleen (G) of naïve hNSG mice 4 months post-engraftment. Human T cell subsets in thymus are highlighted (F). uninjured hNSG mice had more human PBLs at 4 months post-engraftment than at 2 months ( Fig. 3A; Fig. 3-figure  145 supplement 1A) -all circulating human leukocyte subsets including T lymphocytes (hCD3), B lymphocytes (hCD19) 146 and myeloid cells (hCD33) increased in number and proportion as a function of time post-engraftment ( Fig. 3B; Fig. 3-147 figure supplement 1B). 148 149
Five weeks after SCI we noted marked differences in circulating leukocyte responses between the two cohorts. In the 150 2-month cohort, the total numbers of circulating human leukocytes increased after SCI ( Fig. 3E,F; Fig. 3 - figure  151 supplement 1E,F). However, this was unlikely an injury-dependent effect and is better explained by continued 152 maturation of the human immune system. Indeed, by 35 dpi cells from mice in the 2-month cohort were now engrafted 153 >3 months with the relative proportion of hCD45+ PBLs in most mice increased to levels identical to engraftment at 3 154 months (compare Fig. 1A,B ) and similar to pre-injury values found in the 4-month post-engraftment cohort (compare 155 were modest in the 4-month post-engraftment cohort ( Fig. 4E) and were marked by a selective increase in the 157 proportion of T cells ( Fig. 3F; Fig. 3-figure supplement 1F) . 158 159
Given the importance of the spleen in regulating neuro-immune interactions after SCI (Blomster et al., 2013; Noble et  160 al., 2018), we also quantified human splenocyte subsets in both cohorts 35 dpi ( Fig. 4A,B) . The relative proportions of  161 human T, B, and myeloid cells in spleen reflected their proportions in the blood 35 dpi, which is consistent with the role 162 of the spleen as a reservoir for circulating human leukocytes. Spleens of both groups displayed preferential clustering 163 of hCD3 + T cells in the splenic white pulp. Again, the relative density of T cell clusters was increased in the 4-month 164 post-engraftment cohort (Fig. 4C) . 165 166 leukocytes was increased in SCI mice from the 4-181 month cohort ( Fig. 5A,B) . Additionally, hCD3 + T 182 cells were increased ~10-fold in mice injured at 4 183 months post-engraftment compared to 2 months 184 post-engraftment ( Fig. 5C,D) . (70%:30%) was significantly different than at 2 198 months (50%:50%) ( Fig. 7C) .
200
We've previously shown that large, phagocytic 201 human macrophages populate the injured spinal 202 cord in humanized mice (Carpenter et al., 2015). 203
The spinal cord lesions of both hNSG cohorts 204 contained a subset of large (presumably activated 205 phagocytic) human macrophages expressing hCD4 206 on their cell membrane ( Fig. 6D,E Previously, we found that lesion pathology was exacerbated and functional recovery was impaired in hNSG mice as 239 compared to non-engrafted immunocompromised NSG control mice (Carpenter et al., 2015). However, our previous 240 study occurred before we understood the importance of post-engraftment timing on maturation of the human immune 241 system hNSG mice. Here, we compared lesion pathology and functional recovery in non-engrafted NSG mice and 242 age-matched hNSG mice with a mature (4-month post-engraftment) human immune system after spinal contusion 243 injury. hNSG mice develop larger lesions ( Fig. 7A,B ) with significantly worse recovery of hindlimb function as defined 244 by open field locomotor analysis ( Fig. 7C ) and foot-falls on the horizontal ladder test ( Fig. 7E) . Worse hindlimb 245 function at 35 dpi correlated with an increase in lesion size (Fig. 7D) . These data indicate that post-injury activation of 246 human immune cells, like mouse immune cells, can exacerbate lesion pathology and impair neurological recovery after 247 SCI (Carpenter et al., 2015). 248 249
Discussion 250
Previously, we characterized the anatomical, functional and hematological consequences of a contusive spinal cord 251 injury (SCI) in humanized NSG (hNSG) mice (Carpenter et al., 2015). Although the data in that report were the first to 252 illustrate the feasibility of using humanized mice to test hypotheses related to neuro-immune interactions after SCI, the 253 report was limited in scope and did not evaluate the implications of developmental timing on human immune cell 254 composition and function. In humanized mice, human T cells help promote the maturation and functional development of human B cells (Lang et  262 al., 2013). In athymic nude rats, which lack T cells, B cells are similarly impaired but can be rescued by reconstituting 263
adult rats with T cells (Milićević et al., 2005) . More human macrophages were also found in spinal cord lesions in the 4-month cohort (as compared with lesions 287 from hNSG mice in the 2-month cohort). A more robust myeloid cell response to SCI was observed even though the 288 percentage of human myeloid cells in blood or spleen of hNSG mice was not different between mice in the 2-and 4-289 month post-engraftment cohorts. Again, this is evidence that a more functionally mature human immune system exists 290
It is not clear how T cells influence the development and maturation of 264 other immune cells but interactions between T cells and progenitor cells in the bone
in hNSG mice at 4 months post-engraftment. 291 292 We also found that many large, phagocytic human macrophages expressed membrane hCD4. Rat is routinely used to phenotype helper T-cells, is also expressed by human and rat monocytes (Crocker et al., 1987; 297 Mestas and Hughes, 2004) . Ligating this co-receptor on monocytes/macrophages triggers intracellular signaling 298 cascades that augment macrophage maturation and activation (Szabo et al., 1990 , Zhen et al., 2014 . Although the 299 functional significance of CD4 + macrophages in CNS trauma has not been determined, macrophage expression of 300 CD8, another co-receptor typically found on cytotoxic T cells, has been linked to pathological effector functions and 301 pathology in the rat models of multiple sclerosis (Hiraki et al., 2009 ), stroke (Boddaert et al., 2018) and spinal cord 302 injury . Therefore, humanized mice could prove to be a useful tool for studying the functional 303 importance of activating CD4 (and possibly CD8) co-receptors on CNS macrophages. 304 305
Using confocal microscopy, we confirmed several examples of cell-cell contact between human T cells and human 306 macrophages in the injured spinal cord. Membrane hCD3 expression was abundant at the interface between human 307 macrophages and human T cells (see Fig. 6-figure supplement 2) . Redistribution of CD3, a major component of the 308
T cell receptor (TCR) complex, is essential in the formation of immune synapses and T cell activation by macrophages 309 and other antigen presenting cells (Fooksman et al., 2010 In the present report, data suggest that the intraspinal human immune response contributes to pathology and 316 subsequent functional impairment. Indeed, after SCI in 4-month post-engraftment hNSG mice with mature functional 317 human immune systems, a prominent intraspinal human T cell infiltrate was associated with exacerbated lesion 318 pathology and impaired spontaneous recovery. Still, we previously provided evidence that axons migrate along lesion 319 matrix proteins in close proximity to human immune cells in hNSG mice, indicating possible reparative functions of 320 human immune cells. Together, these data demonstrate that in hNSG mice, the human immune system actively 321 responds to SCI hNSG mice and that these cells exert biological effects on the lesion epicenter. To prove a causal role 322
for human T cell-mediated pathology or repair, human immune cell manipulation studies are needed. 323 324
Considerations for using humanized mice in CNS injury models 325 326
Long-term health and viability of humanized mice may be a concern for those interested in brain or spinal cord aging 327 studies or if chronic survival times are required. We were consistently able to keep hNSG mice alive for 9-12 months of 328 age without major health concerns. Sporadic premature death of hNSG mice does occur but cause of death is difficult 329 to determine. Anemia may be one factor contributing to premature mortality after engraftment because of rapid onset anemia (Rongvaux et al., 2014) . SCI in hNSG did not increase the frequency 334 of death, although we did not allow survival beyond 35 days post-SCI. hNSG mice developed infrequent health 335 problems (e.g., ruffled fur, cataracts in one or both eyes and spontaneous hindlimb inflammation). Importantly, SCI did 336 not increase the number or severity of these health issues. We did note that hNSG mice appear healthier when they 337 are engrafted with human UCB stem cells close to 72 hours after birth. Moreover, hNSG mice are available through commercial vendors, although current costs may be prohibitive for larger 358 studies (~$1,000 USD/mouse). Fortunately, it is possible to reduce costs and generate hNSG mice "in house". In our 359 experience, it is possible to generate a litter of 8-10 hNSG mice for ~$1,500 Vancouver, BC) via intrahepatic injection. After injection pups were allowed to recover for several minutes on a heat 390 source set to 37°C before returning pups to their dams for normal maturation and weaning at 21-24 days of age. hNSG 391 mice are healthy and can be used over extended periods of time for experimentation. On occasion, hNSG mice can 392 have a rough coat and decreased body weight compared to non-humanized NSG mice. Cataract formation in one or 393 both eyes was also observed in a few animals, and 1/78 hNSG mice developed spontaneous hindlimb inflammation 394 around the knee. Median survival of our initial cohort of hNSG mice was 293 days. While death was preceded by rapid 395 weight loss over ~1 week, there were no phenotypic changes associated with classical graft-versus-host disease 396
(GvHD), such as loss of fur and advanced infiltration of cells into organs and tissues. Only 4% (3/78) of hNSG mice 397 displayed evidence of T-cell expansion (excessive thymus size or proportion of T cells in peripheral blood), further 398 supporting a lack of graft-versus-host disease (GvHD) in this model. Both male and female hNSG mice generated 399 robust human immune systems. The efficiency and composition of engrafted human immune cells differed only slightly 400 between male and female NSG mice in blood at 4 months post-engraftment. Total engraftment by human immune 401 cells was 7.5% higher in females (63.0 ± 14.2% vs. 55.5 ± 17.2%), with more B cells (67.2 ± 16.3% vs. 56.2 ± 17.6%) 402
and fewer myeloid cells (3.91 ± 2.8% vs. 6.73 ± 3.8%). Overall, these data support the use of both male and female 403 humanized mice in experimental studies. 404 405
SCI & animal care 406 407 hNSG mice (2-4 months old) were used for SCI experiments. hNSG mice used for comparison of time post-408 engraftment were generated 2 months apart using same UCB donor but underwent SCI and all other outcomes at the 409 same time. Mice were anesthetized with ketamine (90-120mg/kg, i.p.) and xylazine (7-10mg/kg, i.p.) then injected with 410 gentamicin sulfate (5mg/kg, s.q.). Aseptic conditions were maintained during all surgical procedures. Mice were placed 411 on a warming pad during surgery to maintain body temperature. Hair was shaved at the region of the thoracic spinal 412 cord and skin treated with a sequence of betadine-70% ethanol-betadine. A small midline incision was made to expose 413 the mid-thoracic vertebra, then a partial laminectomy was performed. A 60 KDyne (mild) T9 contusion injury was 414 performed using an Infinite Horizon Impactor (Precision Systems and Instrumentation, Lexington, KY). Immediately 415 after impact, the muscle overlaying the injury site was sutured, followed by closure of the wound with sutures or 416 staples. After surgery, mice were placed in cages on heating pads and monitored until they recovered consciousness. 417
Animals were supplemented with sterile saline (1-2mL, s.q.) and softened food to eat ad libitum during recovery. 418
Bladders were expressed twice daily, and urine underwent weekly pH testing to detect bladder infections. Gentocin 419 antibiotic was subcutaneously administered once a day at 5 mg/kg for 5 days post-injury (dpi). 420 421
Hindlimb locomotor function assessment  422  423 The open-field Basso Mouse Scale (BMS) was used to assess hindlimb paralysis and functional recovery (Basso et  424 al ., 2006) . Pre-SCI testing occurred after acclimating mice to the open field on multiple days with dim lighting to  425  minimize anxiety. Post-SCI testing occurred on 1, 3, 5, 7, 14, 21, 28, and 35 dpi. Mice explored the open field and  426 were scored over a period of 4 minutes. Two individuals that were blinded to the experimental condition averaged the 427 left and right hindlimb score for each mouse to obtain a single score per mouse at each time point. 428 429
The horizontal ladder test was performed before SCI and at 35 dpi. The horizontal ladder contained 33 rungs spaced 430 ~1 cm apart and elevated ~1 cm off of a clear mirrored surface for viewing of paws from the side and below using a 431 digital video recorder to capture each trial. Mice were acclimated to the ladder test over 3 separate days with a 432 minimum of 3 runs per session before acquiring baseline values. Mice were handled by a single experimenter (RSC). 433
During testing days, each mouse was allowed a minimum of 3 passes along the horizontal ladder to reduce trial-trial 434 variability. Mice were allowed to rest for ~15-20 minutes between each pass/trial. Digital videos were assessed by a 435 single experimenter (RRJ) blinded to group designations, with playback at 0.35x speed using VLC media player (v.3.0; 436
VideoLAN Organization) on a computer screen of a minimum 13-inch diameter. Each trial (3/mouse) was viewed and 437 analyzed 3 times by the experimenter and averaged to acquire a single value for each trial. This was done to reduce 438 observer error and variability, and a subset of trials were assessed by a second reviewer (RSC) to ensure accuracy. 439 440
Tissue collection 441 442
For survival blood sampling, blood was collected from the submandibular vein using a lancet and EDTA-coated 443 capillary tube (Sarstedt Inc., Thermo Fisher Scientific, Waltham, MA). For endpoint tissue collection, mice were first 444 deeply anesthetized with ketamine and xylazine. Blood was collected via cardiac puncture, placed in EDTA-coated 445 collection tubes, and inverted several times. Red blood cells were lysed with ammonium chloride and resuspended in 446 0.1M phosphate buffered saline (PBS) with 2% FBS (flow buffer) for flow cytometry. Spleens were isolated, weighed, 447
and placed in Hank's Balanced Salt Solution (HBSS). Spleens were minced with sterile dissection scissors and 448 smashed through a 40 µm sterile filter using the plunger of a 3 mL syringe and 10 mL of HBSS. Mouse femurs and 449 tibiae were removed, cleaned, and placed in a small volume of HBSS. Bone marrow cells were isolated by either 450 flushing bones with 10 mL HBSS or by crushing in a mortar and pestle with HBSS. Cell counts for bone marrow and 451 spleen were obtained by standard hemocytometer counting techniques, while total blood was analyzed with a 452
Hemavet 950fs multi-species hematology system capable of analyzing whole blood cells with 5-part differential, 453 platelets, and red blood cells. To obtain serum, blood was collected as above, inserted into gel separation tubes 454 coated with clotting activator, and centrifuged at 10 5 x g for 5 minutes. For experiments using tissue sections, mice 455
were perfused with 0.1M PBS followed by 4% paraformaldehyde. Fixed tissues (i.e., the spleen, thymus and spinal 456 cords) were cryopreserved for 48 hours in 30% sucrose, cryosectioned at 10 µm onto glass slides, and stored at -20°C 457 until staining. 458 459
Immunolabeling and imaging 460 461
Antibody sources, working concentrations, protocols, and validations were previously reported (Carpenter et al., 2015); 462 a summary of antibodies for immunolabeling are included in activator, and after 30 minutes tubes were centrifuged at 10,000xg for 5 minutes. Serum was collected, aliquoted into 519 1.5mL Eppendorf tubes, and stored at -80°C. 520 521
Ex vivo purification and stimulation of human splenocytes 522 523
hNSG mice (4-6 months old) were anesthetized and spleens dissected as previously described. Splenocytes were 524 diluted in IMDM and counted on a manual hemocytometer with a 1:1 ratio of 0.4% Trypan Blue to quantify live cells. 525
Contaminating mouse splenocytes were depleted from cell preparations by incubating with MACS anti-mouse CD45 526 magnetic microbeads (Miltenyi Biotec, Auburn, CA) and then washing through magnetic LD Columns as per 527 manufacturer's protocol. Enrichment of human cells was verified via flow cytometry of the depleted and cultured 528 fractions: depleted fraction contained >90% mouse CD45 + splenocytes, while the cultured fraction contained >90% 529 human CD45 + splenocytes (see Fig. 2-figure supplement 1 error of the mean except where noted. One sample from both 2-and 4-month post-engraftment groups was not run on 556
the Hemavet due to inadequate blood volume at 35 dpi and was excluded from analysis in Fig. 4C&D . Adobe 557
Photoshop CS5 v.12 (Adobe Systems Inc., San Jose, CA) was used to generate figures. 558 559
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Authors declare no competing interests. 569 570 hNSG mouse injured at 4-months post-engraftment. The co-localization of hCD3 and hCD4 on small cells confirms 825 their T cell identity. In this example, two human T cells are in direct contact with a human CD4 + macrophage. Note the 826 absence of hCD3 labeling on the human macrophage. A large, isolated T cell with immunoblast-like morphology is also 827 identified. 828
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